BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21559457)

  • 1. Amplification of the angiogenic signal through the activation of the TSC/mTOR/HIF axis by the KSHV vGPCR in Kaposi's sarcoma.
    Jham BC; Ma T; Hu J; Chaisuparat R; Friedman ER; Pandolfi PP; Schneider A; Sodhi A; Montaner S
    PLoS One; 2011 Apr; 6(4):e19103. PubMed ID: 21559457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma.
    Ma T; Patel H; Babapoor-Farrokhran S; Franklin R; Semenza GL; Sodhi A; Montaner S
    Angiogenesis; 2015 Oct; 18(4):477-88. PubMed ID: 26092770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells.
    Vart RJ; Nikitenko LL; Lagos D; Trotter MW; Cannon M; Bourboulia D; Gratrix F; Takeuchi Y; Boshoff C
    Cancer Res; 2007 May; 67(9):4042-51. PubMed ID: 17483315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KSHV G-protein coupled receptor vGPCR oncogenic signaling upregulation of Cyclooxygenase-2 expression mediates angiogenesis and tumorigenesis in Kaposi's sarcoma.
    Medina MV; D Agostino A; Ma Q; Eroles P; Cavallin L; Chiozzini C; Sapochnik D; Cymeryng C; Hyjek E; Cesarman E; Naipauer J; Mesri EA; Coso OA
    PLoS Pathog; 2020 Oct; 16(10):e1009006. PubMed ID: 33057440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for virally induced reactive oxygen species in Kaposi's sarcoma herpesvirus tumorigenesis.
    Ma Q; Cavallin LE; Leung HJ; Chiozzini C; Goldschmidt-Clermont PJ; Mesri EA
    Antioxid Redox Signal; 2013 Jan; 18(1):80-90. PubMed ID: 22746102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma.
    Montaner S; Sodhi A; Ramsdell AK; Martin D; Hu J; Sawai ET; Gutkind JS
    Cancer Res; 2006 Jan; 66(1):168-74. PubMed ID: 16397229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis?
    Sodhi A; Montaner S; Gutkind JS
    FASEB J; 2004 Mar; 18(3):422-7. PubMed ID: 15003988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor.
    Sodhi A; Chaisuparat R; Hu J; Ramsdell AK; Manning BD; Sausville EA; Sawai ET; Molinolo A; Gutkind JS; Montaner S
    Cancer Cell; 2006 Aug; 10(2):133-43. PubMed ID: 16904612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of dephosphorylated 4EBP after mTOR inhibition with rapamycin is sufficient to disrupt paracrine transformation by the KSHV vGPCR oncogene.
    Martin D; Nguyen Q; Molinolo A; Gutkind JS
    Oncogene; 2014 May; 33(18):2405-12. PubMed ID: 23708663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Akt/TSC/mTOR activation by the KSHV G protein-coupled receptor: emerging insights into the molecular oncogenesis and treatment of Kaposi's sarcoma.
    Montaner S
    Cell Cycle; 2007 Feb; 6(4):438-43. PubMed ID: 17329974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The small GTPase Rac1 links the Kaposi sarcoma-associated herpesvirus vGPCR to cytokine secretion and paracrine neoplasia.
    Montaner S; Sodhi A; Servitja JM; Ramsdell AK; Barac A; Sawai ET; Gutkind JS
    Blood; 2004 Nov; 104(9):2903-11. PubMed ID: 15231571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha.
    Sodhi A; Montaner S; Patel V; Zohar M; Bais C; Mesri EA; Gutkind JS
    Cancer Res; 2000 Sep; 60(17):4873-80. PubMed ID: 10987301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antineoplastic effect of 1α,25(OH)
    Suares A; Tapia C; González-Pardo V
    J Steroid Biochem Mol Biol; 2019 Feb; 186():122-129. PubMed ID: 30308321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral G protein-coupled receptor up-regulates Angiopoietin-like 4 promoting angiogenesis and vascular permeability in Kaposi's sarcoma.
    Ma T; Jham BC; Hu J; Friedman ER; Basile JR; Molinolo A; Sodhi A; Montaner S
    Proc Natl Acad Sci U S A; 2010 Aug; 107(32):14363-8. PubMed ID: 20660728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1α,25(OH)
    Tapia C; Principe G; González-Pardo V
    Biochimie; 2023 Sep; 212():76-84. PubMed ID: 37062469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiopoietin-like 4: a novel molecular hallmark in oral Kaposi's sarcoma.
    Hu J; Jham BC; Ma T; Friedman ER; Ferreira L; Wright JM; Accurso B; Allen CM; Basile JR; Montaner S
    Oral Oncol; 2011 May; 47(5):371-5. PubMed ID: 21421336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Kaposi's Sarcoma-Associated Herpesvirus ORF34 Protein Interacts and Stabilizes HIF-2α via Binding to the HIF-2α bHLH and PAS Domains.
    Haque M; Kousoulas KG
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual inhibition of PI3Kalpha and mTOR as an alternative treatment for Kaposi's sarcoma.
    Chaisuparat R; Hu J; Jham BC; Knight ZA; Shokat KM; Montaner S
    Cancer Res; 2008 Oct; 68(20):8361-8. PubMed ID: 18922908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal adhesion kinase is required for KSHV vGPCR signaling.
    He M; Bakken T; Kassimova A; Boshoff C; Philpott N; Cannon ML
    Mol Carcinog; 2012 Apr; 51(4):339-51. PubMed ID: 21538577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR.
    Bais C; Van Geelen A; Eroles P; Mutlu A; Chiozzini C; Dias S; Silverstein RL; Rafii S; Mesri EA
    Cancer Cell; 2003 Feb; 3(2):131-43. PubMed ID: 12620408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.